First Trust Advisors LP Dynavax Technologies Corp Transaction History

First Trust Advisors LP

  • $118 Billion
  • Q2 2025

A detailed history of First Trust Advisors LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, First Trust Advisors LP holds 45,848 shares of DVAX stock, worth $476,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,848
Previous 140,051 67.26%
Holding current value
$476,819
Previous $1.82 Million 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$9.4 - $12.87 $885,508 - $1.21 Million
-94,203 Reduced 67.26%
45,848 $454,000
Q1 2025

May 14, 2025
BUY
$12.39 - $14.4 $913,105 - $1.06 Million
73,697 Added 111.07%
140,051 $1.82 Million
Q4 2024

Feb 13, 2025
BUY
$10.28 - $13.66 $682,119 - $906,395
66,354 New
66,354 $847,000
Q1 2024

May 13, 2024
BUY
$11.7 - $14.98 $30.8 Million - $39.4 Million
2,628,622 Added 1397.8%
2,816,676 $35 Million
Q4 2023

Feb 13, 2024
SELL
$13.09 - $14.98 $1.48 Million - $1.69 Million
-112,848 Reduced 37.5%
188,054 $2.63 Million
Q3 2023

Nov 13, 2023
BUY
$12.64 - $14.99 $1.37 Million - $1.62 Million
108,397 Added 56.31%
300,902 $4.44 Million
Q2 2023

Aug 14, 2023
BUY
$9.85 - $13.17 $153,985 - $205,886
15,633 Added 8.84%
192,505 $2.49 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $984,356 - $1.24 Million
-104,275 Reduced 37.09%
176,872 $1.74 Million
Q4 2022

Feb 09, 2023
SELL
$10.27 - $13.29 $244,456 - $316,341
-23,803 Reduced 7.81%
281,147 $2.99 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $1.03 Million - $1.81 Million
103,936 Added 51.71%
304,950 $3.18 Million
Q2 2022

Aug 12, 2022
BUY
$7.45 - $12.83 $1.5 Million - $2.58 Million
201,014 New
201,014 $2.53 Million
Q3 2018

Oct 25, 2018
SELL
$11.85 - $16.0 $458,559 - $619,152
-38,697 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$15.15 - $20.75 $526,204 - $720,709
-34,733 Reduced 47.3%
38,697 $590,000
Q1 2018

Apr 23, 2018
SELL
$14.65 - $19.9 $483,039 - $656,142
-32,972 Reduced 30.99%
73,430 $1.46 Million
Q4 2017

Feb 08, 2018
BUY
$17.3 - $24.08 $1.84 Million - $2.56 Million
106,402
106,402 $1.99 Million

Others Institutions Holding DVAX

# of Institutions
295
Shares Held
120M
Call Options Held
294K
Put Options Held
86.1K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email